Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injectable Buprenorphine During Transition Out of Prison: A Partially Randomized Preference Pilot Trial

NCT06880718 is registered in ClinicalTrials.gov with Lifespan as lead sponsor.

NCT NCT06880718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06880718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injectable Buprenorphine During Transition Out of Prison: A Partially Randomized Preference Pilot Trial
Lead sponsor
Lifespan
Phase
Phase 4
Overall status
Recruiting
Start date
February 18, 2026
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

buprenorphine, incarceration, medications for opioid use disorder, opioid use disorder